Accès libre

Relationship between ECG Findings and Serum Biomarkers in COVID-19 Patients

À propos de cet article

Citez

1. Anjorin AA. The coronavirus disease 2019 (COVID-19) pandemic: A review and an update on cases in Africa. Asian Pac J Trop Med. 2020;13:99-203. doi: 10.4103/1995-7645.281612.10.4103/1995-7645.281612 Search in Google Scholar

2. Akçay Ş, Ozlu T, Yılmaz A. Radiological approaches to COVID-19 pneumonia. Turk J Med Sci. 2020;50:604-610. doi: 10.3906/sag-2004-160.10.3906/sag-2004-160719598732299200 Search in Google Scholar

3. Abobaker A, Raba AA, Alzwi A. Extrapulmonary and atypical clinical presentations of COVID-19. J Med Virol. 2020;92:2458-2464. doi: 10.1002/jmv.26157.10.1002/jmv.26157730050732520401 Search in Google Scholar

4. Jin J. Screening for cardiovascular disease risk with ECG. JAMA. 2018;319:2346. doi: 10.1001/jama.2018.7311.10.1001/jama.2018.731129896628 Search in Google Scholar

5. Supreeth RN, Francis J. Fragmented QRS-Its significance. Indian Pacing Electrophysiol J. 2020;20:27-32. doi: 10.1016/j.ipej.2019.12.005.10.1016/j.ipej.2019.12.005699439631843558 Search in Google Scholar

6. Bektaş O, Çerik IB, Çerik HÖ, et al. The relationship between severe acute respiratory syndrome coronavirus 2 (SARSCOV-2) pandemic and fragmented QRS. J Electrocardiol. 2020;62:10-13. doi: 10.1016/j.jelectrocard.2020.07.009.10.1016/j.jelectrocard.2020.07.009737527132736117 Search in Google Scholar

7. Barman HA, Atici A, Alici G, et al. The effect of the severity COVID-19 infection on electrocardiography. Am J Emerg Med. 2021;46:317-322. doi: 10.1016/j.ajem.2020.10.005.10.1016/j.ajem.2020.10.005753992733059987 Search in Google Scholar

8. Mccullough SA, Goyal P, Krishnan U, Cho JJ, Safford MM, Okın PM. Electrocardiographic findings in coronavirus disease-19: insights on mortality and underlying myocardial processes. J Card Fail. 2020;26:626-632. doi: 10.1016/j.cardfail.2020.06.005.10.1016/j.cardfail.2020.06.005729351832544622 Search in Google Scholar

9. Angeli F, Spanevello A, De Pontia R, et al. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020;78:101-106. doi: 10.1016/j.ejim.2020.06.015.10.1016/j.ejim.2020.06.015730592832586646 Search in Google Scholar

10. Yenerçağ M, Arslan U, Şeker O, et al. Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019. J Cardiovasc Med. 2021;22:197-203. doi: 10.2459/JCM.0000000000001135.10.2459/JCM.000000000000113533186236 Search in Google Scholar

11. Ozcan S, Cakmak HA, Ikitimur B, et al. The prognostic significance of narrow fragmented QRS on admission electrocardiogram in patients hospitalized for decompensated systolic heart failure. Clin Cardiol. 2013;36:560-564. doi: 10.1002/clc.22158.10.1002/clc.22158664952223754185 Search in Google Scholar

12. Milano SS, de Moura Júnior OV, Souza Bordin AA, Marques GL. C-reactive protein is a predictor of mortality in ST-segment elevation acute myocardial infarction. Int J Cardiovasc Sci. 2019;32:118-124. doi: 10.5935/2359-4802.20180086.10.5935/2359-4802.20180086 Search in Google Scholar

13. Shrivastava AK, Singh HV, Raizada A, Singh SK. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 2015;67:89-97. doi: 10.1016/j.ehj.2014.11.005.10.1016/j.ehj.2014.11.005 Search in Google Scholar

14. Efe SÇ, Candan ÖÖ, Gündoğan C, et al. Value of C-reactive protein/albumin ratio for predicting ischemia in myocardial perfusion scintigraphy. Mol Imaging Radionucl Ther. 2020;29:112-117. doi: 10.4274/mirt.galenos.2020.88261.10.4274/mirt.galenos.2020.88261758374933094574 Search in Google Scholar

15. Santos HO, Moreira Izidoro LF. Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment. Int J Cardiovasc Sci. 2018;31:532-537. doi: 10.5935/2359-4802.20180038.10.5935/2359-4802.20180038 Search in Google Scholar

16. Ataoğlu HE, Yılmaz F, Uzunhasan I, et al. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res. 2010;38:52-61. doi: 10.1177/147323001003800106.10.1177/14732300100380010620233513 Search in Google Scholar

17. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw128.10.1093/eurheartj/ehw12827206819 Search in Google Scholar

18. Yiğit Ö, Cete Y, Eken C, Göksu E. The sensitivity and specificity of high sensitive CRP, d-dimer and IL-6 in acute coronary syndrome. Balkan Med J. 2011;28:429-434. doi: 10.5152/balkanmedj.2011.010.10.5152/balkanmedj.2011.010 Search in Google Scholar

19. Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013;13:82-94. doi: 10.2174/1568026611313020002.10.2174/156802661131302000223470072 Search in Google Scholar

20. Kocaman SA, Çetin M, Kırış T, et al. The importance of fragmented QRS complexes in prediction of myocardial infarction and reperfusion parameters in patients undergoing primary percutaneous coronary intervention. Turk Kardiyol Dern Ars. 2012;40:213-222. doi: 10.5543/tkda.2012.36937.10.5543/tkda.2012.3693722864316 Search in Google Scholar

21. Radwan HI, Mansour KS, Al-Daydamony MM, Mohammed RS. Fragmented QRS complex as a predictor of high risk in acute coronary syndrome. Cardiol Cardiovasc Res. 2019;3:71-79. doi: 10.11648/j.ccr.20190303.16.10.11648/j.ccr.20190303.16 Search in Google Scholar

22. Zhao Q, Zhang Q, Hou J, Yu B. Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention. Acta Cardiol Sin. 2018;34:13-22. doi: 10.6515/ACS.201801_34(1).20170903A. Search in Google Scholar

eISSN:
2457-5518
Langue:
Anglais